← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

IBEX Limited (IBEX) 10-Year Financial Performance & Capital Metrics

IBEX • • Industrial / General
TechnologyIT ServicesCustomer Experience & Business Process OutsourcingCustomer Service BPO
AboutIBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company provides ibex Connect, a customer engagement solution that comprises customer service, technical support, revenue generation, and other value-added outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that includes digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience. As of October 1, 2021, the company operated 33 customer engagement and three customer acquisition delivery centers. It serves banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, travel and hospitality, and utility industries. The company was formerly known as IBEX Holdings Limited and changed its name to IBEX Limited in September 2019. The company was incorporated in 2017 and is headquartered in Washington, District of Columbia. IBEX Limited is a subsidiary of The Resource Group International Limited.Show more
  • Revenue $558M +9.8%
  • EBITDA $64M +8.4%
  • Net Income $37M +9.5%
  • EPS (Diluted) 2.36 +28.3%
  • Gross Margin 30.91% +3.4%
  • EBITDA Margin 11.44% -1.2%
  • Operating Margin 8.35% +7.7%
  • Net Margin 6.6% -0.2%
  • ROE 24.57% +15.2%
  • ROIC 19.49% +12.5%
  • Debt/Equity 0.52 +28.5%
  • Interest Coverage 28.53 -62.8%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Excellent 3Y average ROE of 23.3%
  • ✓Strong 5Y profit CAGR of 36.5%
  • ✓Strong Piotroski F-Score: 7/9
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 13.9% through buybacks
  • ✓Efficient asset utilization: 2.0x turnover

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y6.62%
3Y4.24%
TTM12.86%

Profit (Net Income) CAGR

10Y-
5Y36.53%
3Y19.77%
TTM22.55%

EPS CAGR

10Y-
5Y39.92%
3Y27.08%
TTM47.09%

ROCE

10Y Avg9.78%
5Y Avg16.83%
3Y Avg19.88%
Latest22.4%

Peer Comparison

Customer Service BPO
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
EXLSExlService Holdings, Inc.6.77B42.6335.2312.74%11.91%25.35%3.29%0.39
TASKTaskUs, Inc.412.23M11.6523.307.64%7.11%14.35%24.21%0.61
GGenpact Limited7.97B46.2216.226.48%11.01%21.67%6.65%0.60
IBEXIBEX Limited511.21M37.9616.089.77%7.14%28.81%5.34%0.52
CNXCConcentrix Corporation2.6B42.1811.3735.2%3.25%7.28%16.46%1.39
CNDTConduent Incorporated316.48M2.070.93-9.83%-4.85%-17.35%0.84
TTECTTEC Holdings, Inc.161.18M3.32-0.49-10.36%-0.84%-6.4%4.03

Profit & Loss

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Sales/Revenue+323.02M334.03M342.2M368.38M405.13M443.39M492.85M523.12M508.57M558.27M
Revenue Growth %-0.03%0.02%0.08%0.1%0.09%0.11%0.06%-0.03%0.1%
Cost of Goods Sold+260.59M276.19M252.93M254.59M276.25M335.25M373.97M374.99M356.54M385.69M
COGS % of Revenue0.81%0.83%0.74%0.69%0.68%0.76%0.76%0.72%0.7%0.69%
Gross Profit+62.43M57.84M89.28M113.79M128.88M108.14M118.88M148.13M152.03M172.58M
Gross Margin %0.19%0.17%0.26%0.31%0.32%0.24%0.24%0.28%0.3%0.31%
Gross Profit Growth %--0.07%0.54%0.27%0.13%-0.16%0.1%0.25%0.03%0.14%
Operating Expenses+309.51M335.07M363.3M361.34M109.37M91.09M98.25M107.65M112.6M125.97M
OpEx % of Revenue0.96%1%1.06%0.98%0.27%0.21%0.2%0.21%0.22%0.23%
Selling, General & Admin281.72M306.12M332.93M321.72M350.42M080.15M88.66M93.14M108.74M
SG&A % of Revenue0.87%0.92%0.97%0.87%0.86%-0.16%0.17%0.18%0.19%
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses27.8M28.96M30.37M39.61M-241.06M91.09M18.1M18.98M19.46M17.23M
Operating Income+8.56M-2.33M-17.78M6.8M19.51M17.05M20.63M40.48M39.43M46.61M
Operating Margin %0.03%-0.01%-0.05%0.02%0.05%0.04%0.04%0.08%0.08%0.08%
Operating Income Growth %--1.27%-6.65%1.38%1.87%-0.13%0.21%0.96%-0.03%0.18%
EBITDA+21.22M11.51M-5.59M27.7M43.98M31.16M38.73M59.46M58.89M63.84M
EBITDA Margin %0.07%0.03%-0.02%0.08%0.11%0.07%0.08%0.11%0.12%0.11%
EBITDA Growth %--0.46%-1.49%5.95%0.59%-0.29%0.24%0.54%-0.01%0.08%
D&A (Non-Cash Add-back)12.65M13.83M12.18M20.89M24.47M14.12M18.1M18.98M19.46M17.23M
EBIT7.1M-3.44M-18.91M6.8M19M17.05M20.67M41.12M41.5M47.57M
Net Interest Income+-5.13M-6.39M-3.09M-7.71M-9.43M-9.03M-1.25M-152K1.56M-679K
Interest Income0007.25M0043K640K2.07M955K
Interest Expense3.67M5.28M1.96M7.25M9.43M9.03M1.29M792K514K1.63M
Other Income/Expense-5.13M-6.39M-3.09M-7.71M-9.43M-1.89M-1.25M-152K1.56M-679K
Pretax Income+3.43M-8.72M-20.87M-904K10.09M15.15M19.38M40.33M40.99M45.93M
Pretax Margin %0.01%-0.03%-0.06%-0%0.02%0.03%0.04%0.08%0.08%0.08%
Income Tax+1.86M295K-108K3.62M2.31M2.06M-2.08M8.74M7.33M9.07M
Effective Tax Rate %0.46%1.03%0.76%5%0.77%0.86%1.11%0.78%0.82%0.8%
Net Income+1.57M-9.01M-15.88M-4.52M7.77M13.09M21.46M31.58M33.66M36.86M
Net Margin %0%-0.03%-0.05%-0.01%0.02%0.03%0.04%0.06%0.07%0.07%
Net Income Growth %--6.74%-0.76%0.72%2.72%0.68%0.64%0.47%0.07%0.1%
Net Income (Continuing)1.57M-9.01M-20.76M-4.52M7.77M13.09M21.46M31.58M33.66M36.86M
Discontinued Operations004.88M15.48M000000
Minority Interest3.64M20M20M0000000
EPS (Diluted)+0.09-0.51-0.90-0.260.440.151.151.671.842.36
EPS Growth %--6.74%-0.76%0.71%2.69%-0.66%6.67%0.45%0.1%0.28%
EPS (Basic)0.09-0.51-0.90-0.260.440.161.181.741.902.51
Diluted Shares Outstanding17.69M17.69M17.69M17.69M17.69M18.38M18.72M18.89M18.25M15.72M
Basic Shares Outstanding17.69M17.69M17.69M17.69M17.69M17.65M18.23M18.2M17.7M14.68M
Dividend Payout Ratio4.18%---------

Balance Sheet

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Total Current Assets+80.75M88.58M82M81.78M86.04M141.37M142.35M158.61M179.96M145.62M
Cash & Short-Term Investments9.45M21.32M13.52M8.87M21.87M57.84M48.83M57.43M62.72M15.35M
Cash Only9.45M21.32M13.52M8.87M21.87M57.84M48.83M57.43M62.72M15.35M
Short-Term Investments0000000000
Accounts Receivable65.89M63.85M60.35M64.12M57.94M72.61M75.43M92.37M107.64M118.7M
Days Sales Outstanding74.4569.7764.3763.5352.259.7855.8664.4577.2577.61
Inventory0505K00000000
Days Inventory Outstanding-0.67--------
Other Current Assets5.41M3.26M2.62M00673K10.95M2.19M1.89M2.13M
Total Non-Current Assets+57.69M63.65M75.08M106.53M109.2M132.91M151.83M134.72M113.95M127.6M
Property, Plant & Equipment23.33M22.81M18.9M82.31M84.59M106.7M125.03M112.07M89.01M94.84M
Fixed Asset Turnover13.84x14.64x18.11x4.48x4.79x4.16x3.94x4.67x5.71x5.89x
Goodwill11.89M11.83M11.83M11.83M11.83M11.83M11.83M11.83M11.83M11.83M
Intangible Assets9.13M5.97M4.18M2.93M2.78M3.21M700K000
Long-Term Investments288K294K392K227K2.94M258K382K000
Other Non-Current Assets9.74M18.35M34.56M6.71M4.83M6.66M4.61M6.23M8.82M13.76M
Total Assets+138.44M152.23M157.08M188.3M195.24M274.29M294.18M293.32M293.9M273.21M
Asset Turnover2.33x2.19x2.18x1.96x2.08x1.62x1.68x1.78x1.73x2.04x
Asset Growth %-0.1%0.03%0.2%0.04%0.4%0.07%-0%0%-0.07%
Total Current Liabilities+99.39M99.89M116.23M111.38M105.65M105.72M97.77M73.26M71M79.94M
Accounts Payable11.18M13.69M13.15M9.93M10.35M5.98M20.3M18.7M16.72M18.69M
Days Payables Outstanding15.6618.0918.9814.2313.686.5119.8218.2117.1217.69
Short-Term Debt46.55M43.3M51.18M41.84M40.14M26.72M28.89M413K660K0
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities01M21.9M19.07M18.59M35.83M3.56M000
Current Ratio0.81x0.89x0.71x0.73x0.81x1.34x1.46x2.16x2.53x1.82x
Quick Ratio0.81x0.88x0.71x0.73x0.81x1.34x1.46x2.16x2.53x1.82x
Cash Conversion Cycle-52.34--------
Total Non-Current Liabilities+19.3M23.61M12.89M68.29M73.43M87.91M82.95M70.1M57.11M58.97M
Long-Term Debt12.21M14.65M9.01M7.18M3.78M1.8M339K600K867K0
Capital Lease Obligations00866K58.6M62.04M71.88M76.32M64.85M53.44M54.6M
Deferred Tax Liabilities4.62M5.34M61.29M147K117K86K0000
Other Non-Current Liabilities1.09M1.11M2.31M1.61M7.06M11.14M2.3M3.26M1.67M3.23M
Total Liabilities118.69M123.49M129.13M179.67M179.09M193.63M180.72M143.36M128.1M138.91M
Total Debt+58.75M57.95M62.96M118.25M105.97M112.52M105.54M78.9M67.02M69.75M
Net Debt49.3M36.63M49.44M109.38M84.1M54.67M56.71M21.47M4.3M54.41M
Debt / Equity2.98x1.19x1.31x13.71x6.56x1.39x0.93x0.53x0.40x0.52x
Debt / EBITDA2.77x5.04x-4.27x2.41x3.61x2.73x1.33x1.14x1.09x
Net Debt / EBITDA2.32x3.18x-3.95x1.91x1.75x1.46x0.36x0.07x0.85x
Interest Coverage2.33x-0.44x-9.09x0.94x2.07x1.89x16.00x51.11x76.71x28.53x
Total Equity+19.75M48.74M47.95M8.63M16.15M80.66M113.46M149.96M165.8M134.31M
Equity Growth %-1.47%-0.02%-0.82%0.87%3.99%0.41%0.32%0.11%-0.19%
Book Value per Share1.122.752.710.490.914.396.067.949.088.54
Total Shareholders' Equity16.1M28.74M27.95M8.63M16.15M80.66M113.46M149.96M165.8M134.31M
Common Stock1K1K12K12K12K2K2K2K2K1K
Retained Earnings-70.44M-110.03M-126.06M-117.18M-109.53M-110.68M-76.36M-44.78M-11.12M25.74M
Treasury Stock000000-3.41M-3.68M-25.37M-103.34M
Accumulated OCI22.34M22.55M37.8M29.59M29.46M33.18M5.79M-6.31M-7.91M-6.34M
Minority Interest3.64M20M20M0000000

Cash Flow

Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Jun 2025
Cash from Operations+3.04M6.65M-5.75M2.2M51.72M16.08M40.01M41.86M35.9M45.67M
Operating CF Margin %0.01%0.02%-0.02%0.01%0.13%0.04%0.08%0.08%0.07%0.08%
Operating CF Growth %-1.18%-1.86%1.38%22.49%-0.69%1.49%0.05%-0.14%0.27%
Net Income3.43M-8.72M-15.94M19.41M7.77M13.09M21.46M31.58M33.66M36.86M
Depreciation & Amortization12.65M13.83M12.42M21.8M24.47M14.12M18.1M18.98M19.46M17.23M
Stock-Based Compensation945K323K8.94M5.26M359K5.36M1.85M4.61M3.77M5.43M
Deferred Taxes1.84M-1.72M-6.24M-13.44M0-1.91M-5.17M4.53M344K-2.88M
Other Non-Cash Items5.13M6.39M5.33M13.38M11.51M12.41M15.04M15.85M15.95M15.32M
Working Capital Changes-20.96M-3.46M-10.26M-44.22M7.61M-26.98M-11.27M-33.69M-37.28M-26.3M
Change in Receivables-20.04M4.01M758K-18.02M9.04M-13.33M-9.71M-12.3M0-19.26M
Change in Inventory0000000000
Change in Payables7.49M2.34M4.41M9M0-4.01M2.31M-3.75M-2.25M6.25M
Cash from Investing+-11.58M-9.75M-5.44M-9.08M-4.83M-20.82M-25.92M-19.04M-8.86M-18.38M
Capital Expenditures-10.88M-9.93M-5.76M-6.23M-4.28M-20.82M-25.92M-18.95M-8.86M-18.38M
CapEx % of Revenue0.03%0.03%0.02%0.02%0.01%0.05%0.05%0.04%0.02%0.03%
Acquisitions----------
Investments----------
Other Investing178K177K715K810K-552K00000
Cash from Financing+12.19M14.98M3.19M2.55M-33.87M40.9M-22.13M-13.61M-21.73M-74.66M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid-6.56M-1M-146K-1.6M0-4M0000
Share Repurchases----------
Other Financing200K190K00-14.67M-1.05M35K2.05M366K4.31M
Net Change in Cash----------
Free Cash Flow+-7.84M-3.29M-11.51M-4.03M47.44M-4.75M14.09M22.91M27.05M27.29M
FCF Margin %-0.02%-0.01%-0.03%-0.01%0.12%-0.01%0.03%0.04%0.05%0.05%
FCF Growth %-0.58%-2.5%0.65%12.76%-1.1%3.97%0.63%0.18%0.01%
FCF per Share-0.44-0.19-0.65-0.232.68-0.260.751.211.481.74
FCF Conversion (FCF/Net Income)1.94x-0.74x0.36x-0.49x6.66x1.23x1.86x1.33x1.07x1.24x
Interest Paid00009.43M01.25M152K514K1.63M
Taxes Paid0000002.16M4.28M7.69M11.95M

Key Ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)7.96%-26.32%-32.85%-15.97%62.72%27.04%22.11%23.98%21.32%24.57%
Return on Invested Capital (ROIC)9.3%-2.26%-14.59%4.74%13.41%10.85%10.13%17.77%17.32%19.49%
Gross Margin19.33%17.32%26.09%30.89%31.81%24.39%24.12%28.32%29.89%30.91%
Net Margin0.49%-2.7%-4.64%-1.23%1.92%2.95%4.35%6.04%6.62%6.6%
Debt / Equity2.98x1.19x1.31x13.71x6.56x1.39x0.93x0.53x0.40x0.52x
Interest Coverage2.33x-0.44x-9.09x0.94x2.07x1.89x16.00x51.11x76.71x28.53x
FCF Conversion1.94x-0.74x0.36x-0.49x6.66x1.23x1.86x1.33x1.07x1.24x
Revenue Growth-3.41%2.44%7.65%9.98%9.44%11.16%6.14%-2.78%9.77%

Revenue by Geography

202020212022202320242025
UNITED STATES396.16M--509.17M493.01M537.78M
UNITED STATES Growth-----3.17%9.08%
Offshore---221.91M244.82M282.29M
Offshore Growth----10.32%15.30%
Non-US---13.95M15.55M20.49M
Non-US Growth----11.51%31.75%
United States of America--476.81M---
United States of America Growth------
Others .--16.76M---
Others . Growth------
U-428.83M----
U Growth------
Other Countries20.17M14.83M----
Other Countries Growth--26.48%----

Frequently Asked Questions

Valuation & Price

IBEX Limited (IBEX) has a price-to-earnings (P/E) ratio of 16.1x. This is roughly in line with market averages.

Growth & Financials

IBEX Limited (IBEX) reported $579.7M in revenue for fiscal year 2025. This represents a 79% increase from $323.0M in 2016.

IBEX Limited (IBEX) grew revenue by 9.8% over the past year. This is steady growth.

Yes, IBEX Limited (IBEX) is profitable, generating $41.4M in net income for fiscal year 2025 (6.6% net margin).

Dividend & Returns

IBEX Limited (IBEX) has a return on equity (ROE) of 24.6%. This is excellent, indicating efficient use of shareholder capital.

IBEX Limited (IBEX) generated $31.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.